Polyneuropathy (peripheral) - in the ICD-10-CM Index

Browse the ICD-10-CM codes with references applicable to the clinical term "polyneuropathy (peripheral)"

• Polyneuropathy (peripheral) - G62.9 Polyneuropathy, unspecified

  • alcoholic - G62.1 Alcoholic polyneuropathy

  • amyloid (Portuguese) - E85.1 Neuropathic heredofamilial amyloidosis

    • transthyretin-related (ATTR) familial - E85.1 Neuropathic heredofamilial amyloidosis

  • arsenical - G62.2 Polyneuropathy due to other toxic agents

  • critical illness - G62.81 Critical illness polyneuropathy

  • demyelinating, chronic inflammatory (CIDP) - G61.81 Chronic inflammatory demyelinating polyneuritis

  • diabetic - See: Diabetes, polyneuropathy;

  • drug-induced - G62.0 Drug-induced polyneuropathy

  • hereditary - G60.9 Hereditary and idiopathic neuropathy, unspecified

    • specified NEC - G60.8 Other hereditary and idiopathic neuropathies

  • idiopathic - G60.9 Hereditary and idiopathic neuropathy, unspecified

    • progressive - G60.3 Idiopathic progressive neuropathy

  • in (due to)

    • alcohol - G62.1 Alcoholic polyneuropathy

      • sequelae - G65.2 Sequelae of toxic polyneuropathy

    • amyloidosis, familial (Portuguese) - E85.1 Neuropathic heredofamilial amyloidosis

    • antitetanus serum - G61.1 Serum neuropathy

    • arsenic - G62.2 Polyneuropathy due to other toxic agents

      • sequelae - G65.2 Sequelae of toxic polyneuropathy

    • avitaminosis NEC - E56.9 Vitamin deficiency, unspecified

    • beriberi - E51.11 Dry beriberi

    • collagen vascular disease NEC - M35.9 Systemic involvement of connective tissue, unspecified

    • deficiency (of)

      • B (-complex) vitamins - E53.9 Vitamin B deficiency, unspecified

      • vitamin B6 - E53.1 Pyridoxine deficiency

    • diabetes - See: Diabetes, polyneuropathy;

    • diphtheria - A36.83 Diphtheritic polyneuritis

    • drug or medicament - G62.0 Drug-induced polyneuropathy

      • correct substance properly administered - See: Table of Drugs and Chemicals, by drug, adverse effect;

      • overdose or wrong substance given or taken - See: Table of Drugs and Chemicals, by drug, poisoning;

    • endocrine disease NEC - E34.9 Endocrine disorder, unspecified

    • herpes zoster - B02.23 Postherpetic polyneuropathy

    • hypoglycemia - E16.2 Hypoglycemia, unspecified

    • infectious

      • disease NEC - B99 Other and unspecified infectious diseases

      • mononucleosis - B27.91 Infectious mononucleosis, unspecified with polyneuropathy

    • lack of vitamin NEC - E56.9 Vitamin deficiency, unspecified

    • lead - G62.2 Polyneuropathy due to other toxic agents

      • sequelae - G65.2 Sequelae of toxic polyneuropathy

    • leprosy - A30.9 Leprosy, unspecified

    • Lyme disease - A69.22 Other neurologic disorders in Lyme disease

    • metabolic disease NEC - E88.9 Metabolic disorder, unspecified

    • microscopic polyangiitis - M31.7 Microscopic polyangiitis

    • mumps - B26.84 Mumps polyneuropathy

    • neoplastic disease - See Also: Neoplasm; - D49.9 Neoplasm of unspecified behavior of unspecified site

    • nutritional deficiency NEC - E63.9 Nutritional deficiency, unspecified

    • organophosphate compounds - G62.2 Polyneuropathy due to other toxic agents

      • sequelae - G65.2 Sequelae of toxic polyneuropathy

    • parasitic disease NEC - B89 Unspecified parasitic disease

    • pellagra - E52 Niacin deficiency [pellagra]

    • polyarteritis nodosa - M30.0 Polyarteritis nodosa

    • porphyria - E80.20 Unspecified porphyria

    • radiation - G62.82 Radiation-induced polyneuropathy

    • rheumatoid arthritis - See: Rheumatoid, polyneuropathy;

    • sarcoidosis - D86.89 Sarcoidosis of other sites

    • serum - G61.1 Serum neuropathy

    • syphilis (late) - A52.15 Late syphilitic neuropathy

      • congenital - A50.43 Late congenital syphilitic polyneuropathy

    • systemic

      • connective tissue disorder - M35.9 Systemic involvement of connective tissue, unspecified

      • lupus erythematosus - M32.19 Other organ or system involvement in systemic lupus erythematosus

    • toxic agent NEC - G62.2 Polyneuropathy due to other toxic agents

      • sequelae - G65.2 Sequelae of toxic polyneuropathy

    • transthyretin-related (ATTR) familial amyloid - E85.1 Neuropathic heredofamilial amyloidosis

    • triorthocresyl phosphate - G62.2 Polyneuropathy due to other toxic agents

      • sequelae - G65.2 Sequelae of toxic polyneuropathy

    • tuberculosis - A17.89 Other tuberculosis of nervous system

    • uremia - N18.9 Chronic kidney disease, unspecified

    • vitamin B12 deficiency - E53.8 Deficiency of other specified B group vitamins

      • with anemia (pernicious) - D51.0 Vitamin B12 deficiency anemia due to intrinsic factor deficiency

        • due to dietary deficiency - D51.3 Other dietary vitamin B12 deficiency anemia

    • zoster - B02.23 Postherpetic polyneuropathy

  • inflammatory - G61.9 Inflammatory polyneuropathy, unspecified

    • chronic demyelinating (CIDP) - G61.81 Chronic inflammatory demyelinating polyneuritis

    • sequelae - G65.1 Sequelae of other inflammatory polyneuropathy

    • specified NEC - G61.89 Other inflammatory polyneuropathies

  • lead - G62.2 Polyneuropathy due to other toxic agents

    • sequelae - G65.2 Sequelae of toxic polyneuropathy

  • nutritional NEC - E63.9 Nutritional deficiency, unspecified

  • postherpetic (zoster) - B02.23 Postherpetic polyneuropathy

  • progressive - G60.3 Idiopathic progressive neuropathy

  • radiation-induced - G62.82 Radiation-induced polyneuropathy

  • sensory (hereditary) (idiopathic) - G60.8 Other hereditary and idiopathic neuropathies

  • specified NEC - G62.89 Other specified polyneuropathies

  • syphilitic (late) - A52.15 Late syphilitic neuropathy

    • congenital - A50.43 Late congenital syphilitic polyneuropathy

Alcoholics: Persons who have a history of physical or psychological dependence on ETHANOL.

Lead: A soft, grayish metal with poisonous salts; atomic number 82, atomic weight 207.2, symbol Pb.